Hana Golding Selected Research

attachment protein G

1/2018	Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains.
1/2016	Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hana Golding Research Topics

Disease

33	Infections 11/2022 - 12/2002
33	Human Influenza (Influenza) 01/2021 - 08/2008
13	Vaccinia 01/2017 - 08/2003
11	Smallpox (Variola) 03/2015 - 08/2003
9	COVID-19 03/2022 - 01/2020
7	Influenza in Birds (Avian Flu) 01/2018 - 08/2008
5	Respiratory Syncytial Virus Infections 01/2020 - 08/2015
4	Fever (Fevers) 12/2020 - 07/2010
4	Virus Diseases (Viral Diseases) 01/2019 - 07/2002
3	Weight Loss (Weight Reduction) 11/2014 - 10/2009
3	HIV Infections (HIV Infection) 02/2007 - 03/2006
2	Pneumonia (Pneumonitis) 01/2017 - 08/2013
1	Pernicious Anemia 03/2022
1	Gastritis 03/2022
1	Thyroiditis 03/2022
1	Tuberculosis (Tuberculoses) 01/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 10/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2017
1	Frailty 03/2017
1	Multiple Sclerosis 02/2016
1	Communicable Diseases (Infectious Diseases) 01/2016
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 08/2015
1	Inflammation (Inflammations) 03/2013
1	Poxviridae Infections 09/2011
1	Neoplasms (Cancer) 01/2011
1	Mpox (monkeypox) 08/2006

Drug/Important Bio-Agent (IBA)

48	VaccinesIBA 03/2022 - 08/2003
26	AntibodiesIBA 01/2022 - 07/2002
11	Neutralizing AntibodiesIBA 03/2022 - 10/2003
11	Hemagglutinins (Hemagglutinin)IBA 10/2020 - 01/2010
11	Influenza Vaccines (Influenza Vaccine)FDA Link 03/2017 - 08/2008
10	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2005
8	EpitopesIBA 11/2022 - 03/2006
8	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 08/2003
6	AntigensIBA 02/2022 - 05/2009
6	Immunoglobulin G (IgG)IBA 01/2022 - 02/2005
6	Monoclonal AntibodiesIBA 10/2020 - 04/2009
4	Peptides (Polypeptides)IBA 01/2016 - 07/2002
4	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 08/2006 - 01/2004
3	Dinoprostone (PGE2)FDA Link 01/2022 - 10/2019
3	Inactivated VaccinesIBA 01/2018 - 01/2011
3	GTP-Binding Proteins (G-Protein)IBA 10/2017 - 08/2015
3	LuciferasesIBA 01/2017 - 05/2013
3	Antiviral Agents (Antivirals)IBA 03/2015 - 01/2010
3	DNA (Deoxyribonucleic Acid)IBA 08/2013 - 08/2006
2	Messenger RNA (mRNA)IBA 03/2022 - 12/2021
2	CytokinesIBA 01/2022 - 01/2017
2	Immunoglobulin M (IgM)IBA 01/2022 - 02/2005
2	Immunoglobulin A (IgA)IBA 01/2022 - 01/2021
2	avian influenza A virus hemagglutininIBA 01/2019 - 10/2017
2	attachment protein GIBA 01/2018 - 01/2016
2	Indicators and Reagents (Reagents)IBA 03/2017 - 08/2011
2	Virulence Factors (Pathogenicity Factors)IBA 10/2016 - 04/2009
2	Subunit VaccinesIBA 11/2014 - 01/2010
2	DNA VaccinesIBA 09/2011 - 05/2009
2	AIDS VaccinesIBA 11/2006 - 03/2006
1	2019-nCoV Vaccine mRNA-1273IBA 03/2022
1	COVID-19 VaccinesIBA 03/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2022
1	Ferritins (Ferritin)IBA 02/2022
1	sortase AIBA 02/2022
1	DH1047IBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Acetylmuramyl-Alanyl-IsoglutamineIBA 12/2020
1	Broadly Neutralizing AntibodiesIBA 10/2020
1	Pattern Recognition ReceptorsIBA 10/2019
1	Vaccine AdjuvantsIBA 10/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	AS03 adjuvantIBA 01/2018
1	Formaldehyde (Formol)FDA Link 10/2017
1	MF59 oil emulsionIBA 01/2017
1	Palivizumab FDA Link 01/2017
1	EmulsionsIBA 01/2017
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 02/2016
1	AfluriaIBA 02/2016
1	Daclizumab (Zenapax)FDA Link 02/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	ElementsIBA 03/2015
1	brincidofovirIBA 03/2015
1	Blocking AntibodiesIBA 12/2014
1	Polysaccharides (Glycans)IBA 04/2014
1	tecovirimatIBA 05/2013
1	Biomarkers (Surrogate Marker)IBA 03/2013
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2013
1	Toll-Like Receptor AgonistsIBA 07/2012
1	C-Reactive ProteinIBA 07/2012
1	Urea (Carbamide)FDA LinkGeneric 05/2012
1	Combined Antibody TherapeuticsIBA 09/2011
1	Attenuated VaccinesIBA 01/2011
1	VimentinIBA 01/2011
1	AluminumIBA 01/2010
1	Neuraminidase (Sialidase)IBA 01/2010
1	HIV AntibodiesIBA 01/2010
1	EnzymesIBA 01/2010
1	DryVax vaccineIBA 10/2007
1	Synthetic Vaccines (Recombinant Vaccines)IBA 08/2006

Therapy/Procedure

6	Therapeutics 01/2022 - 10/2009
1	Drug Therapy (Chemotherapy) 10/2017
1	Immunotherapy 10/2017